Publications

Publications2018-11-01T17:01:26+00:00

Science Publications

Cutting-edge research from the Grace Science team has led to breakthroughs in our understanding of NGLY1 functions.

ACS CENTRAL SCIENCE

Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity

Mainstream Publications

Grace Science’s innovative approach to rare disease has garnered national media attention.

WIRED

A Family’s Race To Cure A Daughter’s Genetic Disease

FAST COMPANY

This Father Founded A Medical Research Startup To Save His Kid’s Life

STANFORD NEWS

A Rare Disease Inspires Stanford Researchers To Find A New Way To Attack Cancer

New York Times

Parents of Children With Rare Diseases Find Hope in For-Profit Companies

Rare Unlocks Common

Grace Science is leveraging NGLY1 biology to treat human disease.

Contact Us